"The firm has an impressive deal list in its repertoire"
PLC Which Lawyer?

News & Events

18 November 2009

Asters advising on creation of the second-largest pharmaceutical company in the world


Asters provided legal advise on Ukrainian merger control law issues, including representation in in-depth merger control investigation by the Antimonopoly Committee of Ukraine (AMC) and obtaining merger clearance in connection with a merger of two global pharmaceutical companies – Schering-Plough Corporation and Merck & Co., Inc. The combined company will use the trade name 'Merck' in the USA and Canada, and ‘MSD' elsewhere.

Merck & Co., Inc. is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. Schering-Plough is an innovation-driven, science-centered global health care company with activities in the human, consumer healthcare, and animal healthcare sectors.

The combined company is a global health care leader with a diversified portfolio of prescription medicines, vaccines, and consumer health products, as well as animal health products. The company now has approximately 106,000 employees and operates in more than 140 countries around the world, including emerging markets.

The filing with the AMC was handled by associates Tetyana Buchko and Maryna Kovalko under the supervision of partner Igor Svechkar.


News Archive

Browse by

Practice Areas:
Industry Sectors:
Search

News Archive

 

Subscribe for News